DEUTSCHE BANK AG\
BankPosition in XERS — Xeris Biopharma Holdings, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in XERS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$3,613,469
-$3,770,177 QoQ
Shares Held
623,012
-33.8% QoQ
Ownership
0.361%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 0.430007768710715.ToString("F0")%
Shared 0.ToString("F0")%
None 99.56999223128929.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $1,164,451,125 across 44 Drug Manufacturers - Specialty & Generic names. XERS ranks #21 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,532,028 | $653,941,023 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
198,777 | $117,870,782 | |
| 3 | VTRS |
Viatris Inc
|
6,512,440 | $87,983,060 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,829,970 | $85,238,695 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
365,345 | $48,130,546 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
523,691 | $25,215,720 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
319,675 | $24,583,006 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
236,885 | $17,967,724 |
All Filings in XERS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,613,469 | 623,012 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $7,383,646 | 940,592 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $12,760,629 | 1,567,645 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,441,448 | 736,927 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,152,674 | 756,407 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $432,563 | 127,600 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $226,665 | 79,532 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $124,427 | 55,301 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $151,479 | 68,543 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $155,285 | 66,079 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $126,629 | 68,081 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $151,640 | 57,878 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $144,833 | 88,855 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $77,969 | 58,624 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $90,075 | 57,741 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $102,532 | 66,580 | Shares | Defined | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||